Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company focused on CNS disorder therapeutics, has announced a conference call and live webcast for October 30, 2024, at 8:30 a.m. Eastern Time. The event will provide a corporate update and discuss the company's financial results for Q3 2024, ending September 30.

Participants can join the call by phone using a provided registration link. The webcast will be accessible under the 'Events & Presentations' section of the company's website. Attendees are advised to log in 5-10 minutes early to register and install any necessary software.

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, October 30, 2024, to provide a corporate update and discuss details of the Company's financial results for the quarter ended September 30, 2024.

To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.

The live and archived webcast can be accessed under "Events & Presentations" in the Investors section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

FAQ

When will Intra-Cellular Therapies (ITCI) report its Q3 2024 financial results?

Intra-Cellular Therapies (ITCI) will report its Q3 2024 financial results on Wednesday, October 30, 2024, during a conference call and webcast at 8:30 a.m. Eastern Time.

How can investors access ITCI's Q3 2024 earnings call?

Investors can access ITCI's Q3 2024 earnings call by phone through a registration link provided by the company, or via a live webcast available under the 'Events & Presentations' section of the company's website at www.intracellulartherapies.com.

What will be discussed during Intra-Cellular Therapies' (ITCI) upcoming conference call?

During the upcoming conference call, Intra-Cellular Therapies (ITCI) will provide a corporate update and discuss the company's financial results for the quarter ended September 30, 2024.

What is the main focus of Intra-Cellular Therapies (ITCI) as a company?

Intra-Cellular Therapies (ITCI) is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders.